| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.4 | 0.02 |